Plasma membrane CA2+-atpase sulfhydryl modifications: Implication for oxidized red cell

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 43, Issue 5, 2012, Pages 1252-1257

  Pengpanichpakdee, Namphaung ^a   Thadtapong, Tanapon ^a   Auparakkitanon, Saranya ^b   Wilairat, Prapon ^a  

^a Mahidol University ^*  (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Calmodulin; PMCA; Sulfhydryl agent; Thalassemia

Indexed keywords

EID: 84868133663     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Berridge M J, Lipp P, Bootman MD. The versatility and universality of calcium signaling. Nature Rev Mol Cell Biol 2000; 1: 11-21.
2. Bookchin RM, Ortiz OE, Shalev O, et al. Calcium transport and ultrastructure of red cells in b-thalassemia intermedia. Blood 1988; 72: 1602-7.
3. Bootman MD, Berridge MJ, Roderick HL. Calcium signaling: more messengers, more channels, more complexity. Curr Biol 2002; 12: R563-5.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
5. Dissayabutra T, Tosukhowong P, Seksan P. The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress. J Med Assoc Thai 2005; 88: S317-21.
6. Fucharoen S, Winichagoon P. Thalassemia in Southeast Asia: problems and strategy for prevention and control. Southeast Asian J Trop Med Public Health 1992; 23: 647-55.
7. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 3rd ed. Oxford: Oxford University Press, 1989.
8. 2+ -ATPase of animal cells: structure, function and regulation. Arch Biochem Biophys 2008; 476: 65-74.
9. 2+ pumps revealed by a photoactivatable phospholipidic probe. J Biol Chem 2009; 284: 4823-8.
10. Rund D, Rachmilewitz E. b-Thalassemia. N Eng J Med 2005; 353: 1135-46.
11. Saez ME, Ramirez-Lorca R, Moron FJ, Ruiz A. The therapeutic potential of the calpain family: new aspects. Drug Discov Today 2006; 11: 917-23.
12. Sarkadi B, Enyedi A, Foldes-Papp Z, Gardos G. Molecular characterization of the in situ red cell membrane calcium pump by limited proteolysis. J Biol Chem 1986; 261: 9552-7.
13. Sastry PS, Rao KS. Apoptosis and the nervous system. J Neurochem 2000; 74: 1-20.
14. Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol 2002; 9: 123-6.
15. Shalev O, Mogilner S, Shinar E, Rachmilewitz EA, Schrier SL. Impaired erythrocyte calcium homeostasis in b-thalassemia. Blood 1984; 64: 564-6.
16. Suthipark KU, Likidlilid A, Fucharoen S, et al. Red cell and plasma calcium, copper and zinc in beta-thalassemia/hemoglobin E. Southeast Asian J Trop Med Public Health 1991; 22: 171-5.
17. Tesoriere L, D'Arpa D, Butera D, et al. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients. Free Radical Res 2001; 34: 529-40.
18. 2+-ATPase. Arch Biochem Biophys 1988; 267: 317-27.
19. 2+-ATPase by hydrogen peroxide and protection by calmodulin. Biochemistry 2003; 42: 12001-10.